Additionally, Luo et al. demonstrated that pseudolaric acid B (PAB) inhibited NSCLC progression through the ROS/AMPK/mTOR/autophagy signaling pathway (Luo D. et al., 2024). Here, PRKAA2 is linked to non-small cell lung carcinoma.